Etoposide – Etoposide-LENS conc. for solution for infusion 20 mg /ml bottle of 5 ml

$21.00

Description

Latin name

ETOPOSIDE-LANS

Release form

Concentrate for solution for infusion.

Packaging

In a bottle of 5 ml of concentrate. In a cardboard box 1 bottle.

Indications

Germ cell tumors (tumors of the testis, choriocarcinoma)

ovarian cancer

small cell and non-small cell lung cancer

Hodgkin

non-Hodgkin’s lymphoma

gastric cancer (for monotherapy and in combination therapy)

Ewing’s sarcoma

Kaposi’s sarcoma

neuroblastoma

breast cancer (with metastases to the liver, pleura)

acute non-lymphoblastic leukemia

mesothelioma.

Contraindications

Severe myelodepression

severe dysfunction of the liver and kidneys

pregnancy

children under 2 years of age

hypersensitivity to podophyllus or its derivatives.

Use during pregnancy and lactation

Etoposide is contraindicated in pregnancy. If necessary, use during lactation should stop breastfeeding.

During treatment and within 3 months after its completion, patients of childbearing age must use effective methods of contraception.

In experimental studies, etoposide has a teratogenic and embryotoxic effect.

Composition

1 ml (1 vial) contains:

Active substances: etoposide 20 mg (100 mg).

Dosage and administration of

I / O for 30 “60 min (previously diluted with 0.9% sodium chloride solution or 5% glucose solution to a final concentration of 0.2 “0.4 mg / ml) – 50 “100 mg / m2 / day for 4 “5 days, every 3-4 weeks or 100 “125 mg / m2 on days 1, 3, 5. The drug is mainly used in combination with other chemotherapeutic agents. Repeated courses are carried out only after normalization of peripheral blood counts.

Side effects

From the hematopoietic system: leukopenia, anemia less often – thrombocytopenia.

From the digestive system: nausea, vomiting rarely – anorexia, mucositis, diarrhea when used in high doses – toxic reactions from the liver.

From the side of the central nervous system and peripheral nervous system: drowsiness, fatigue damage to the peripheral nervous system.

From the side of metabolism: hyperuricemia with high doses – metabolic acidosis.

From the cardiovascular system: tachycardia, arterial hypotension.

From the reproductive system: azoospermia, amenorrhea.

Allergic reactions: chills, fever, bronchospasm.

Dermatological reactions: alopecia.

› º °Ñ ÑÑ ² ½ ½ ¾ ² · ° ¸ ¼ ¾ ´ ¹ÑÑ ² ¸

ŸÑ ¸ ¾ ´ ½ ¾ ²Ñ ¼ ½ ½ ¾ ¼ ¿Ñ ¸ ¼ ½ ½ ¸ ¸ с ´Ñ у ³ ¸ ¼ ¸ ¿Ñ ¿ °Ñ °Ñ ° ¼ ¸, ² · ² °ÑŽÑ‰ ¸ ¼ ¸ ¼ ¸ » ¾ ´ ¿Ñ сс ¸ÑŽ ² ¾ · ¼ ¾ ¶ ½ ¾ ° ´ ´ ¸Ñ ¸ ² ½ ¾ у ³ ½ Ñ ½ ¸ фу ½ ºÑ† ¸ ¸ º ¾ÑÑ ½ ¾ ³ ¾ ¼ ¾ · ³ °.

ŸÑ ¸ ¾ ´ ½ ¾ ²Ñ ¼ ½ ½ ¾ ¼ ¿Ñ ¸ ¼ ½ ½ ¸ ¸ с ц ¸Ñ ¿ » °Ñ ¸ ½ ¾ ¼ ² ¾ · ¼ ¾ ¶ ½ ¾ у ¼ ½ÑŒÑˆ ½ ¸ º » ¸Ñ ½Ñ ° ÑÑ ¾ ¿ ¾ · ¸ ´ ° ¸ у ² » ¸Ñ‡ ½ ¸ ³ ¾ Ñ ¾ ºÑ ¸Ñ‡ ½ ¾ÑÑ ¸.

¦ ¸ º » ¾Ñ ¿ ¾Ñ ¸ ½ ² ² с ¾ º ¸Ñ… ´ ¾ · °Ñ… ¼ ¾ ¶ Ñ Ñƒ ¼ ½ÑŒÑˆ °Ñ ь º » ¸Ñ ½Ñ ÑÑ ¾ ¿ ¾ · ¸ ´ ° ¸ у ² » ¸Ñ‡ ¸Ñ ь ¿Ñ ¾ ´ ¾ » ¶ ¸Ñ »ÑŒ ½ ¾ÑÑ ь ³ ¾ ´ ¹ÑÑ ² ¸Ñ, ¿Ñ ¸ ÑÑ ¾ ¼ ² ¾ · ¼ ¾ ¶ ½ ¾ ус ¸ » ½ ¸ » ¹ º ¾ ¿ ½ ¸ ¸.

Storage conditions

Store at 15-30 ° C.

Shelf life

3 years.

Deystvuyushtee substance

­topozid

Terms and conditions

prescription